In this role, Dr Lippman will lead all aspects of the clinical, regulatory and medical affairs functions at Noven.
Prior to joining Noven, Dr Lippman served Ethicon, a Johnson & Johnson company, as worldwide vice president of medical affairs and chief medical officer and as a member of that company’s global management board.
Dr Lippman holds a medical degree from New York Medical College and a Masters in Public Health from Harvard University School of Public Health.
Peter Brandt, president and CEO of Noven, said: “Dr Lippman’s appointment further expands the industry experience of a Noven team committed to establishing Noven as a high growth specialty pharmaceutical company.”